R. Matorras et al., Recombinant human FSH versus highly purified urinary FSH: a randomized study in intrauterine insemination with husbands' spermatozoa, HUM REPR, 15(6), 2000, pp. 1231-1234
A randomized trial was carried out comparing recombinant FSH (rFSH) and hig
hly purified urinary FSH (uFSH) in intrauterine insemination (IUI) with hus
bands' spermatozoa, A total of 45 women received rFSH (139 cycles), while 4
6 women received uFSH (155 cycles). The starting dose was 150 IU/day s.c.,
beginning on the second day, and on days 6-7 the dose was adjusted accordin
g to ovarian response, assessed by vaginal ultrasound and plasma oestradiol
concentration. The pregnancy rate according to the intention to treat was
57.8% in rFSH versus 52.2% in uFSH, the corrected pregnancy rates 56.8% and
52.2%, and the cumulative pregnancy rates 69.6 % and 61.0%, but the differ
ences were not statistically significant. The per cycle pregnancy rate was
18.12% in rFSH and 15.48% in u-FSH, also not statistically significant. In
the rFSH group, the consumption of FSH ampoules per cycle was significantly
lower (19.20 +/- 7.02 versus 23.80 +/- 10.78; P < 0.0001); The ratio of oe
stradiol/FSH ampoules was significantly higher in rFSH (56.45 +/- 31.26 ver
sus 46.41 +/- 29.25; P < 0.001). These data indicate that, in IUI cycles, r
FSH has a higher potency than uFSH.